1-216084863-CT-CTT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_206933.4(USH2A):c.5001dupA(p.Gly1668ArgfsTer30) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_206933.4 frameshift
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| USH2A | NM_206933.4 | c.5001dupA | p.Gly1668ArgfsTer30 | frameshift_variant | Exon 25 of 72 | ENST00000307340.8 | NP_996816.3 | |
| USH2A-AS2 | NR_125992.1 | n.266-1854dupT | intron_variant | Intron 2 of 2 | ||||
| USH2A-AS2 | NR_125993.1 | n.137-1854dupT | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Retinitis pigmentosa 39 Pathogenic:1
- -
Rare genetic deafness Pathogenic:1
The Gly1668fs variant in USH2A has not been reported in the literature nor previ ously identified by our laboratory. This frameshift variant is predicted to alte r the protein?s amino acid sequence beginning at position 1668 and lead to a pre mature termination codon 30 amino acids downstream. This alteration is then pred icted to lead to a truncated or absent protein. Therefore, this variant meets ou r criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at